Medtronic PLC
Change company Symbol lookup
Select an option...
MDT Medtronic PLC
TELL Tellurian Inc
PFE Pfizer Inc
AGNC Agnc Investment Corp
AAPL Apple Inc
GRTYA Guaranty Corp
SATS EchoStar Corp
$DJI Dow Jones Industrials
TIKK Tel-Instrument Electronics Corp
TEAM Atlassian Corporation PLC
Go

Health Care : Health Care Equipment & Supplies | Large Cap Blend
Based in Ireland
Company profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company's subsidiaries include Medtronic, Inc. and HeartWare International, Inc.

Postmarket

Last Trade
Delayed
$0.00
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$113.85
Day's Change
1.38 (1.23%)
Bid
--
Ask
--
B/A Size
--
Day's High
113.85
Day's Low
111.70
Volume
(Below Average)
Volume:
3,518,204

10-day average volume:
4,378,259
3,518,204

U.S. Gynecology Robotic Surgery Market worth USD 1.38 Billion at 6.8% CAGR; Rising Demand for Minimally Invasive Procedures to Aid Growth: Fortune Business Insights(TM)

5:57 am ET October 16, 2020 (Globe Newswire) Print

The U.S. gynecology robotic surgery market is set to gain traction from the increasing shift towards minimally invasive procedures over open surgeries as they have lower readmission rates, fewer complications, and provide faster recovery.

This information is given by Fortune Business Insights(TM) in a new report, titled, "U.S. Gynecology Robotic Surgery Market Size, Share & COVID-19 Impact Analysis, By Type (Robotic Systems, Instruments and Accessories, and Services), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Physician's Offices), and Regional Forecast, 2020-2027." The report further states that the market size was USD 1.04 billion in 2019 and is projected to reach USD 1.38 billion by 2027, exhibiting a CAGR of 6.8% during the forecast period.

This Report Answers the Following Questions:

-- Which prominent player would lead in terms of revenue?

-- Which segment is set to dominate the market in terms of share?

-- Will the COVID-19 pandemic affect this market severely?

-- How will organizations promote the adoption of gynecology robotic surgery?

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/u-s-gynecology-robotic-surgery-market-103891

Drivers & Restraints-

Rising Geriatric Population to Boost Growth in the U.S.

The rising adoption of sedentary lifestyles and the increasing geriatric population in the U.S. are further surging the incidence of various gynecological conditions among women. This is set to propel the U.S. gynecology robotic surgery market growth in the coming years.

As per the American Cancer Society, in 2020, the U.S. is likely to showcase approximately 13,800 new cases of cervical cancer. Apart from that, the rising usage of da Vinci robotic surgical systems for such surgeries would accelerate growth. However, the high cost associated with gynecology robotic surgeries may hamper demand.

COVID-19: Cancellation of Non-essential Procedures to Hinder Demand

The outbreak of the COVID-19 pandemic has taken a toll on the healthcare sector. Apart from disturbance in the demand and supply chain, it has caused cancellation and postponement of all non-essential, as well as elective dental, surgical, and medical procedures. This also includes gynecology robotic surgeries.

The main reason behind this is to reallocate and reserve healthcare resources for the coronavirus positive patients. The American Hospital Association mentioned that in the U.S., hospitals and health systems have experienced a decline of 20% in inpatient volume. We are delivering elaborate research reports to help you regain confidence and surge sales.

To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/u-s-gynecology-robotic-surgery-market-103891

Segment-

Instruments & Accessories Segment to Dominate Backed by Rising Number of Hysterectomies

Based on products, the market is segregated into services, instruments & accessories, and robotic systems. Out of these, the instruments & accessories segment earned 57.2% in terms of the U.S. gynecology robotic surgery market share in 2019. It is set to retain its dominant position in the coming years because of the increasing adoption of gynecology robotic surgery, as well as the higher number of hysterectomies.

Competitive Landscape-

Key Players Focus on Collaboration Strategy to Gain Competitive Edge

The U.S. market for gynecology robotics surgery houses numerous companies. Among them, Intuitive Surgical, Inc. is the leading player owing to its expertise in the field of gynecology robotic surgery. Some of the others are participating in the strategy of collaboration and partnership to gain a competitive edge. Below are two latest industry developments:

-- January 2020: Titan Medical and Cambridge Design Partnership (CDP) joined hands to develop a state-of-the-art robotic surgery system. Their main aim is to provide minimally invasive surgery through a single incision.

-- December 2018: Nicholson Center and CMR Surgical unveiled the first training program for Versius based in the U.S. It would provide training programs to 27 surgical teams.

Quick Buy - U.S. Gynecology Robotic Surgery Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/103891

A list of the renowned gynecology robotic surgery providers operating in the U.S.:

-- Intuitive Surgical, Inc. (California, U.S.)

-- TransEnterix Surgical, Inc. (North Carolina, U.S.)

-- Medrobotics Corporation (Massachusetts, U.S.)

-- Titan Medical Inc. (Ontario, Canada)

-- CMR Surgical Limited (Cambridge, U.K.)

-- avateramedical GmbH (Jena, Germany)

-- Medtronic (Dublin, Ireland)

-- Verb Surgical, Inc. (California, U.S.)

-- Olympus Corporation (Tokyo, Japan)

-- Stryker (Michigan, U.S.)

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/u-s-gynecology-robotic-surgery-market-103891

U.S. Gynecology Robotic Surgery Market Table of Contents:

TOC Continued....!

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/u-s-gynecology-robotic-surgery-market-103891

Have a Look at Related Reports:

Robotic Surgical Procedures Market Share and Global Trend By Product Type (Gynecology, Urology, General Surgery, Orthopedics and Others) and Geography Forecast till 2025

Medical Robotic Systems Market Share and Global Trend By By Product (Surgical Robots, Telepresence Robots, Rehabilitation Robots), By End User (Hospitals, Ambulatory Surgery Centers, Rehabilitation Centers) & Geography Forecast till 2026

Netherland Home healthcare Market Share and Global Trend By Product(Continence Care, Wound Care, Ostomy Care, Clinical Nutrition, Respiratory Care, Equipment & Housekeeping Supplies, Disposables) and Geography Forecast till 2026

External Defibrillator Market Share and Global Trend By Product (Automated External Defibrillator (AED), Manual and Semi-automatic External Defibrillator, Wearable External Defibrillator), By End User (Hospitals & Clinics, Schools and other Public Places) and Geography Forecast till 2026

Defibrillators Market Share and Global Trend By Type (Implantable Cardioverter Defibrillator (ICD), Transvenous ICD, External Defibrillator) By End User(Hospitals & Clinics, Ambulatory, Schools and other Public Places) and Geography Forecast till 2026

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights(TM) Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Fortune Business Insights(TM)

LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/u-s-gynecology-robotic-surgery-market-10245

https://ml.globenewswire.com/media/05408ba1-26b1-4fdd-8f48-1af4df373348/small/fbi-logo-tm-png.png

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.